Castro Vázquez, D., Lamana Rodríguez, A., Arribas Castaño, P., Gutiérrez Cañas, I., Villanueva Romero, R., Pérez García, S., . . . Carrión Caballo, M. (2021). The Neuropeptide VIP Limits Human Osteoclastogenesis: Clinical Associations with Bone Metabolism Markers in Patients with Early Arthritis.
Citación estilo ChicagoCastro Vázquez, David, et al. The Neuropeptide VIP Limits Human Osteoclastogenesis: Clinical Associations With Bone Metabolism Markers in Patients With Early Arthritis. 2021.
Cita MLACastro Vázquez, David, et al. The Neuropeptide VIP Limits Human Osteoclastogenesis: Clinical Associations With Bone Metabolism Markers in Patients With Early Arthritis. 2021.
Precaución: Estas citas no son 100% exactas.